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Special Article
The Global Burden of Disease (GBD) study has been instrumental in guiding global health policy development since the early 1990s. 
The GBD 2010 project provided rich information about the key causes of mortality, disability-adjusted life years, and their associated 
risk factors in Japan and provided a unique opportunity to incorporate these data into health planning. As part of the latest update of 
this project, GBD 2013, the Japanese GBD collaborators plan to update and refine the available burden of disease data by incorporat-
ing sub-national estimates of the burden of disease at the prefectural level. These estimates will provide health planners and policy 
makers at both the national and prefectural level with new, more refined tools to adapt local public health initiatives to meet the 
health needs of local populations. Moreover, they will enable the Japanese health system to better respond to the unique challenges 
in their rapidly aging population and as a complex combination of non-communicable disease risk factors begin to dominate the pol-
icy agenda. Regional collaborations will enable nations to learn from the experiences of other nations that may be at different stages 
of the epidemiological transition and have different exposure profiles and associated health effects. Such analyses and improvements 
in the data collection systems will further improve the health of the Japanese, maintain Japan’s excellent record of health equity, and 
provide a better understanding of the direction of health policy in the region. 
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INTRODUCTION
The Global Burden of Disease (GBD) is a an essential tool in 
the global battle to improve health [1]. This project provides a 
systematic approach to calculating comprehensive, consistent, 
and comparable measures of health loss due to diseases, inju-
ries, and their associated risk factors [2]. The latest GBD study, 
pISSN 1975-8375 eISSN 2233-4521 
known as GBD 2010, was conducted by the Institute for Health 
Metrics and Evaluation (IHME) in collaboration with six aca-
demic partners worldwide including the University of Tokyo 
and was published in December 2012 [3,4]. In this study, the 
GBD research team introduced new analytical methods and a 
wider range of data. They also called on experts around the 
world to inform estimation methods with local advice and in-
sights. Through these new approaches, the project’s scope has 
expanded to cover 291 diseases and injuries in 187 countries 
from 21 regions, with estimations of these trends since 1990 
[5]. The GBD 2010 also expanded on previous comparative risk 
factor analyses to cover a total of 67 risk factors [6]. 
The current iteration of the GBD, with its heavy focus on 
comparable and consistent disease burden and risk factor 
analyses between regions, makes it a useful tool not only for 
comparative health system assessment but also for planning 
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public health programs and preventive interventions [7] and 
identifying gaps in international data systems [8]. For example, 
the GBD 2010 was able to describe trends in morbidity and mor-
tality associated with the epidemiological transition in China [9]. 
The GBD studies can also be used, to some extent, for compara-
tive health system assessments that allow for consistent and rig-
orous comparisons of health outcomes between countries with 
diverse social and health systems. For example, comparisons 
between the UK and the European Union clearly elucidated ar-
eas that were underperforming in the UK health system com-
pared to its European counterparts [10]. Individual countries 
have also used the results of these comparisons to inform policy 
debate on issues specific to their own health needs. For exam-
ple, Khang used the GBD 2010 results and project’s detailed 
metrics to publish a review of non-communicable diseases 
(NCD) and strategies for NCD management in Korea [11].
Since the release of the GBD 2010 results, the GBD project has 
been aiming to not only include country experts but also create 
more detailed burden estimates using data that are only acces-
sible to local researchers as well as at a sub-national level, where 
possible [12]. Sub-national estimates of disease burden and 
comparative risk would enable researchers and policy makers to 
explore variation and inequality within countries to better in-
form domestic and international health policy planning. As part 
of this effort to create detailed national estimates, the Depart-
ment of Global Health Policy at the University of Tokyo has com-
menced a three-year project to update the GBD 2012 results at 
the national and sub-national level for Japan. This article de-
scribes the burden of disease, achievements in administering 
health care, future challenges, possible methods for estimating 
sub-national disease burden using the Japanese national bur-
den of disease project, and the potential value of sub-national 
estimates of disease burden for policy makers in Japan. 
THE BURDEN OF DISEASE IN JAPAN
Japan’s achievements in health care administration have be-
come a model for achieving good health at low cost. Japanese 
female life expectancy at birth has ranked number one globally 
since the 1980s. Life expectancy increased by 5.5% over 20 
years, from 81.9 years in 1990 to 86.4 years in 2010 for females 
and from 75.9 years in 1990 to 79.6 years in 2010 among males 
[13]. After rapid improvements in life expectancy due to post-
war advances in child health and vaccinations, this recent 20-
year improvement has primarily resulted from the effective con-
trol of risk factors for NCD mortality [13,14]. For example, reduc-
tions in stroke-related mortality have occurred against a back-
drop of low inequality and universal health coverage [15].
Table 1 shows the highest-ranked causes of disability-ad-
justed life years (DALYs) in Japan in 1990 and 2010 based on 
the GBD 2010 results [16]. In 2010, the highest-ranked causes 
of DALYs in Japan were lower back pain, cerebrovascular dis-
ease, and ischemic heart disease. These causes of DALYs are 
associated with increasing age and have been the highest-
ranked causes of DALYs since 1990. Of the 25 most important 
causes of DALYs, road injury showed the largest decrease, fall-
ing by 42% from 1990 to 2010; however, self-harm remains 
one of the most important causes of DALYs. 
Table 1. Top ten causes contributing to disability-adjusted 
life years in Japan in 1990 and 2010
Rank 1990 2010
1 Cerebrovascular disease Low back pain
2 Low back pain Cerebrovascular disease
3 Ischemic heart disease Ischemic heart disease
4 Stomach cancer Lower respiratory infections
5 Lower respiratory infections Other musculoskeletal
6 Road injury Lung cancer
7 Self-harm Self-harm
8 Other musculoskeletal Stomach cancer
9 Neck pain Neck pain
10 Lung cancer Falls
From Institute for Health Metrics and Evaluation. Global Burden of Disease 
country profile: Japan. Seattle: Institute for Health Metrics and Evaluation; 
2012 [16].
Table 2. Top ten risk factors contributing to disability-adjust-
ed life years in Japan in 1990 and 2010
Rank 1990 2010
1 Dietary risks Dietary risks
2 High blood pressure High blood pressure
3 Smoking Smoking
4 Alcohol use Physical inactivity
5 High fasting plasma glucose High body mass index
6 Ambient PM pollution High fasting plasma glucose
7 High body mass index Alcohol use
8 Occupational risks Ambient PM pollution
9 High total cholesterol High total cholesterol
10 Drug use Occupational risks
From Institute for Health Metrics and Evaluation. Global Burden of Disease 
country profile: Japan. Seattle: Institute for Health Metrics and Evaluation; 
2012 [16].
PM, particulate matter.
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Table 2 shows the contribution of the 10 most important 
risk factors to DALYs in Japan, also drawn from the GBD 2010 
project [16]. In 2012, a country-specific comparative risk as-
sessment was conducted in Japan under the GBD framework. 
This assessment explored these risk factors in more detail us-
ing 2007 datasets and focused on mortality rather than DALYs. 
This national assessment used a systematic review of the liter-
ature and analysis of locally available exposure data to build a 
more detailed picture of these risk factors than was otherwise 
made available at the global level by the GBD 2010 project. In 
doing so, this national assessment focused on only the top 16 
risk factors for ill health in Japan and developed a measure of 
joint risk to represent the complexity of dietary risk factors, 
which are difficult to analyze separately. This national assess-
ment also used richer data to estimate contributions to lost 
life expectancy and probability of death among these risk fac-
tors. In turn, this analysis provided a slightly different insight 
compared to results based only on DALYs such as in the GBD 
2010 results. These results provide more detail about the rela-
tive balance of risks; however, the more detailed data sources 
and restricted set of risk factors has led to some differences 
with the GBD 2010. Nevertheless, both the GBD 2010 and this 
2012 national assessment revealed the same top three risk 
factors including dietary risks, high blood pressure, and smok-
ing, and the 2012 national assessment estimated the effect of 
these risk factors on life expectancy and mortality. The 2012 
national burden of disease analysis was in broad agreement 
with GBD 2010 and demonstrates the power of a national bur-
den of disease estimation conducted under the GBD frame-
work [17]. 
Figure 1 shows the contribution of the top 16 risk factors in 
Japan to changes in life expectancy at 40 as well as the change 
in probability of death in the 15 to 60 and 60 to 75 year age 
groups. Smoking remains a key risk factor among men in Ja-
pan and is responsible for a total of nearly 2 years of lost life 
expectancy at the age of 40 and almost a 15% increase in 
mortality for men aged between 15 and 60 years old. For 
women and men, a complex joint risk factor profile built from 
high blood pressure, blood glucose, low-density lipoprotein 
cholesterol, and body mass index is responsible for a large 
proportion of the mortality. In women, this joint risk factor 
profile alone accounts for nearly a 1.5-year change in their life 
expectancy at 40. Therefore, Japan’s preventive health and 
public health goals in the immediate future should be focused 
on the management of hypertension and risk factors for stroke 
and coronary heart disease that are embedded in this joint risk 
factor model as well as continuing to emphasize dietary inter-
ventions and improved management of suicide risks and de-
pression. 
SUB-NATIONAL ESTIMATES OF RISK AND 
MORTALITY IN JAPAN
It has been suggested that inequality based on region, 
cause, and wealth [18] as well as other risk factors that influ-
ence mortality are increasing in Japan [19]; however, these 
trends have changed since the early 1990s due to economic 
stagnation and other social determinants of health [20]. Given 
the regional variations in health financing and performance 
[15] and the challenges facing Japan’s health system in the fu-
ture [21], a detailed understanding of the sub-national varia-
tions in the causes of death and illness as well as their associ-
ated risk factors is essential. 
Initial research that focuses on identifying variations among 
the causes of death at prefectural and municipal level may be 
the most effective tool to inform sub-national health policy 
making. Figure 2 shows the crude mortality rate among 50 to 
59 year olds in Japan in 2010 [22] and the different patterns of 
mortality across the country. A broad tendency towards high-
er mortality was found in the north. Variations in the culture of 
these areas, urban planning, and the different income struc-
tures and lifestyle patterns across Japan may explain these 
variations in risk. 
The use of geographical differences in mortality demon-
strates the role that sub-national burden estimates can play in 
identifying variations in health and indicate possible causes of 
future divergence in health outcomes between regions. By 
conducting a sub-national analysis, it is possible to identify re-
gion-specific health intervention needs and begin construct-
ing a local policy framework from data collected at the nation-
al level. 
THE ROLE OF SUB-NATIONAL ESTIMATION 
IN POLICY DEVELOPMENT
The 2011 Lancet series on Japan identified major policy 
challenges facing the Japanese health system, considering 
that its universal health care system serves one of the most 
rapidly aging populations. Moreover, this series recommended 
that prefectural governments play a key role in forming and 
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Figure 1. Influence of the 16 key risk factors on mortality outcomes in Japan in 2007. (A) Effect of risk factors on life expectancy 
at age 40. (B) Percentage change in probability of death at age 15 to 60. (C) Percentage change in probability of death at age 
60 to 75 years. Ikeda N, et al. PLoS Med 2012;9(1):e1001160, according to the Creative Commons Attribution License [17]. LDL, 
low-density lipoprotein; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids; BMI, body mass index; HTLV-1, human T-
lymphotropic virus-1; TFA, trans-fatty acids; CVD, cerebrovascular disease; NCD, non-communicable diseases.
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implementing health policy because of the huge regional 
variations in health insurance premiums within Japan [21]. 
However, for prefectural governments to play this role they 
will need to have access to high quality data on both the 
health challenges of their communities, the major risk factors 
for ill health, and past trends in these risk factors. Sub-national 
burden of disease estimates are an ideal tool for engaging 
with policy-makers, and the visualization tools developed by 
the IHME, such as the GBD compare tool [23], make it possible 
for policy-makers with little knowledge of epidemiology to 
quickly and easily compare their prefectural health profile 
with both their own historic profile and the profile of other 
prefectures. 
In addition to enabling the development of locally driven 
plans to modify key risk factors and develop plans to reduce 
future health burdens, these local profiles also enable prefec-
tural governments to identify gaps in the data and make in-
vestments in high quality data collection systems. For modern 
health planning, collecting high quality data is essential. Just 
as the GBD projects have revealed areas for improvement in 
data collection systems globally [8], so too will the local pro-
files naturally lead local organizations to improve their own lo-
cal data systems. This kind of local response to gaps in the 
data may also lead to bottom-up pressure for the develop-
ment of high quality data at a national level as prefectural 
government planners who assign priorities and plan for future 
health needs begin to understand the importance of burden 
estimates where national-level data systems are lacking. 
However, national and sub-national burden of disease cal-
culations cannot be the only analyses. One of the key method-
ological advances of the GBD study is the use of data across 
regions so that nations with sparse data in one health area can 
draw information from data available for other countries in 
the region. This process of data synthesis can also be used for 
national and sub-national estimates. Regional collaborations 
will enable nations at the same stage of epidemiological tran-
sition to share data on exposure risks and effect sizes, espe-
cially where exposures are more common in one nation or 
sub-national region than another. This kind of collaboration 
will also enable these nations to draw on the experience of 
others further along this epidemiological pathway, enabling 
better estimates of current and future NCD burden. Both tech-
nically and institutionally, collaboration is essential to improv-
ing GBD estimates and national and sub-national burden esti-
mations.
DISCUSSION 
In 1990 and 2010, Japan had the lowest age-standardized 
mortality rate and age-standardized rate of years of life losts 
globally [24]. Japanese life expectancy increased from the late 
1950s and remained the highest in the world at the end of the 
1980s. The early increase in longevity during the 1950s to 1960s 
has been credited to the implementation of effective infectious 
disease control programs [14], with the Japanese government 
enacting 32 health laws within ten years after the end of World 
War II [24]. Interventions that prevented infant and child mortal-
ity at that time included clean water, institutional delivery, and 
universal vaccinations. Subsequently, the implementation of 
preventive measures against NCD mortality and the mainte-
nance of an equitable and accessible universal health system 
assured continued gains in the health of the Japanese popula-
tion throughout the epidemiological transition [13]. Because of 
these interventions, Japan came to represent a model for uni-
versal health development [15,25], and these achievements are 
reflected in the results of the GBD 2010 project.
Although Japan performed well in promoting the popula-
Figure 2. Mortality rate among 50 to 59 years old Japanese 
women in 2010. From Vital Health and Social Statistics Divi-
sion. Vital statistics in Japan 2011. Tokyo: Ministry of Health 
Labour and Welfare; 2013 [22].
Rate per 100 000
<284
348-408
408-490
284-348
>490
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tion’s health status, several challenges for the Japanese health 
system remain. Cancer, heart disease, and cerebrovascular dis-
ease, the three leading causes of death, have contributed to 
approximately 50% of the population’s lifetime risk [17]. There-
fore, reducing NCD mortality is the key to prolonging the pop-
ulation’s longevity. Lifestyle risk factors such as smoking are 
the most important factors associated with NCDs. Japan has 
successfully reduced the population’s average blood pressure, 
which can be associated with an unhealthy diet, but the man-
agement of other lifestyle risk factors is still important. The 
next challenge for dietary interventions involves improving 
the methods used to address the complex joint risk factors in-
cluding high blood pressure, blood glucose, low-density lipo-
protein cholesterol, and body mass index. These complex risk 
factors are associated with urbanization, aging, and dietary 
changes as more Western food is incorporated into Japanese 
diets. Therefore, sophisticated interventions and policies at 
both the national and local level will be required.
Although smoking rates have been declining in Japan, 
smoking is still the leading preventable risk factor accounting 
for approximately 50% of adult mortality among young men 
[26]. Highly effective policies for tobacco control are needed in 
Japan, such as higher cigarette prices and stricter tobacco 
control ordinances consistent with the Framework Convention 
on Tobacco Control [27]. Another challenge for the Japanese 
health system is reducing mortality and morbidity rates asso-
ciated with self-harm. More than 30 000 suicides have oc-
curred in Japan every year since 1998, and, although the gov-
ernment has implemented several interventions and strate-
gies to prevent suicide, no substantial improvements have 
been noted [28]. Therefore, effective interventions in the com-
munity and in workplaces are necessary for self-harm preven-
tion.
Although Japan’s health system is famous for maintaining 
equity in health coverage [25], we have shown that significant 
variations in patterns of mortality and risk are evident by age, 
region, and wealth. Maintaining equity in the future will re-
quire interventions and policy instruments to target these re-
gional- and wealth-based inequities. Moreover, any policy de-
velopment should rely on the analysis of risk factors using 
high quality data available at the regional and local level. Be-
ginning with analyses at the prefectural level, it is our goal to 
develop estimates of years of life lost to death and disability as 
well as the major contributing risk factors within the GBD 
framework to guide policy development and inform local 
health decisions. These sub-national estimates will help to in-
form national and prefectural governments about evident 
health challenges and provide detailed assessments of disease 
burden to those who allocate resources and plan interven-
tions. In addition, these sub-national estimates will provide re-
newed impetus to reform the relationships between central 
and local governments as well as improve data systems and 
research [21].
Results of the new GBD 2013 study, which will become the 
most recent burden of disease study, are scheduled to be pub-
lished in late 2014 [4]. This new GBD study will estimate trends 
in the burden of disease throughout 1990 to 2013 with the 
addition of more risk factors than were included in the GBD 
2010. This iteration of the GBD project also aims to use data 
that are directly available from national collaborators. Since 
the release of GBD 2010, the IHME has been actively seeking 
collaborators at the national level to provide more accurate, 
comprehensive, and detailed data as well as to give expert ad-
vice on the findings. A study as broad and complex as the GBD 
project requires many simplifications and approximations, but 
also has many gaps in the data and local knowledge. By incor-
porating national-level collaborators and detailed data, esti-
mates that are even more accurate will hopefully be produced 
and updated frequently. We aim to incorporate our sub-na-
tional estimation process into the next round of the GBD proj-
ect, thus enabling our results on sub-national variation and in-
equality to inform the data on national and sub-national varia-
tion in other parts of the region, which is similar to how the 
variations between nations has informed estimates within re-
gions in the GBD 2010 project [5].
CONCLUSION 
The GBD framework has been essential to understanding 
the successes and challenges in reducing mortality and the 
burden of health in Japan. By providing comprehensive infor-
mation on the national and sub-national disease burden, the 
GBD studies will be crucial in informing future agendas and 
policies in countries throughout the region and especially in 
Japan. However, the quality of the GBD outcomes is depen-
dent on the commitment and involvement of country-level 
collaborators. Nations throughout Asia should commit to this 
unique and challenging project and encourage epidemiolo-
gists throughout the region to participate.
Stuart Gilmour, et al.
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